keine Finanzberatung
🔍 Search…
📊 Portfolio ← All

BDX · Becton, Dickinson and Co.

S&P 500 #252 · NYSE

Risiko 4/10 · MedTech Dividend Stalwart · $166.34 ▲ 4.67%

Kennzahlen

  • Price $166.34
  • Market cap $45.8B
  • P/E (ttm) 28.98
  • Div yield 2.64%
  • 52-wk range $127.59 – $187.35
  • Index rank #252 / —

Wichtigste Risiken

  • Spin-off Execution Risk (Embecta / BD Biosciences) — MED
  • Pricing Pressure (Hospital systems / GPOs) — MED
  • 52-week decline from highs (Price momentum) — MED
  • Tariff / Supply Chain (Global manufacturing) — LOW

Fazit

Becton Dickinson is a global medical technology company making syringes, diagnostics instruments, and infusion systems.

Interaktive Analyse öffnen →

Recherche, keine Anlageberatung.

⚠️ Independent research for a video, not financial advice. Figures from public sources/aggregators, can be stale; risk scores are editorial estimates. Verify before relying on any of it.